OptiBiotix Health Plc
OptiBiotix Health Plc (OPBXF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
opbxf · pe ratio · data through Dec 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for OptiBiotix Health Plc (OPBXF) measures how much investors pay for each dollar of the company's trailing earnings. OPBXF's current PE ratio of N/A is calculated by dividing its stock price of $0.22 by its TTM earnings per share of -$0.04.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-12-31
PE Ratio History
2008 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%9.8x
MedianQ3 · 75%27.4x
Max
At N/A, OPBXF's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
OptiBiotix Health PlcYou OPBXF | $20M | N/A | — | -$0.04 |
 American Hemp Ventures, Inc. AMHV | $16M | N/A | — | — |
 Biofrontera AG BFFTF | $19M | N/A | — | -$13.02 |
 OKYO Pharma Limited EMMLF | $23M | N/A | — | — |
 TPCO Holding Corp. GRAMF | $20M | N/A | — | -$2.32 |
 Kadimastem Ltd KMSTF | $10M | N/A | — | -$6.32 |
 Organicell Regenerative Medicine, Inc. OCEL | $20M | N/A | — | -$0.86 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-12-31Latest FY2022 | 6.55x | $0.03 | -30.8% | |
2021-12-31 FY2021 | 9.47x | $0.07 | -6.5% | |
2020-12-31 FY2020 | 10.13x | $0.06 | — | |
2018-11-30 FY2018 | — | $-0.02 | — | |
2017-11-30 FY2017 | 27.41x | $0.02 | — | |
2016-11-30 FY2016 | — | $-0.02 | — | |
2015-11-30 FY2015 | — | $-0.02 | — | |
2014-11-30 FY2014 | — | $-0.03 | — | |
2012-07-31 FY2012 | — | $-8.78 | — | |
2010-07-31 FY2010 | — | $-4.53 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for OptiBiotix Health Plc (OPBXF) measures how much investors pay for each dollar of the company's trailing earnings. OPBXF's current PE ratio of N/A is calculated by dividing its stock price of $0.22 by its TTM earnings per share of -$0.04.
Frequently asked questions
OPBXF pe ratio · 6 questionsOPBXF's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.22 and TTM EPS of -$0.04. Data sourced from Financial Modeling Prep via OPBXF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · OptiBiotix Health Plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08